MRPL23 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
classical monocyte	13 studies	29% ± 13%	Explore
B cell	12 studies	27% ± 11%	Explore
ciliated cell	12 studies	44% ± 25%	Explore
macrophage	12 studies	30% ± 9%	Explore
conventional dendritic cell	10 studies	36% ± 11%	Explore
epithelial cell	10 studies	44% ± 25%	Explore
fibroblast	10 studies	26% ± 11%	Explore
CD4-positive, alpha-beta T cell	9 studies	36% ± 21%	Explore
natural killer cell	9 studies	17% ± 2%	Explore
T cell	9 studies	24% ± 7%	Explore
monocyte	8 studies	27% ± 11%	Explore
goblet cell	7 studies	30% ± 17%	Explore
regulatory T cell	7 studies	32% ± 14%	Explore
basal cell	6 studies	34% ± 14%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	6 studies	23% ± 7%	Explore
plasma cell	6 studies	41% ± 15%	Explore
CD8-positive, alpha-beta T cell	6 studies	44% ± 21%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	30% ± 15%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	5 studies	27% ± 9%	Explore
non-classical monocyte	5 studies	35% ± 12%	Explore
enterocyte	5 studies	23% ± 8%	Explore
progenitor cell	5 studies	30% ± 12%	Explore
abnormal cell	5 studies	36% ± 20%	Explore
endothelial cell	5 studies	32% ± 13%	Explore
pericyte	5 studies	25% ± 6%	Explore
myeloid cell	5 studies	28% ± 10%	Explore
dendritic cell	5 studies	36% ± 19%	Explore
plasmacytoid dendritic cell	5 studies	27% ± 5%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	17% ± 2%	Explore
exhausted T cell	4 studies	34% ± 13%	Explore
plasmablast	4 studies	39% ± 11%	Explore
epithelial cell of proximal tubule	4 studies	23% ± 6%	Explore
gamma-delta T cell	4 studies	29% ± 13%	Explore
transit amplifying cell	4 studies	33% ± 12%	Explore
connective tissue cell	4 studies	30% ± 4%	Explore
type I pneumocyte	4 studies	28% ± 11%	Explore
type II pneumocyte	4 studies	32% ± 16%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	39% ± 18%	Explore
deuterosomal cell	3 studies	21% ± 6%	Explore
duct epithelial cell	3 studies	19% ± 4%	Explore
secretory cell	3 studies	27% ± 6%	Explore
pancreatic A cell	3 studies	37% ± 14%	Explore
hematopoietic precursor cell	3 studies	43% ± 12%	Explore
kidney loop of Henle epithelial cell	3 studies	24% ± 5%	Explore
enteroendocrine cell	3 studies	41% ± 17%	Explore
intestinal crypt stem cell	3 studies	33% ± 14%	Explore
smooth muscle cell	3 studies	28% ± 7%	Explore
intraepithelial lymphocyte	3 studies	18% ± 1%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	43% ± 6%	Explore
endothelial cell of vascular tree	3 studies	19% ± 2%	Explore
intermediate monocyte	3 studies	47% ± 5%	Explore
mast cell	3 studies	17% ± 0%	Explore
mononuclear phagocyte	3 studies	43% ± 14%	Explore
CD8-positive, alpha-beta memory T cell	3 studies	29% ± 13%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	9 studies	26% ± 8%	Explore
peripheral blood	7 studies	28% ± 5%	Explore
intestine	6 studies	26% ± 11%	Explore
kidney	4 studies	23% ± 6%	Explore
liver	4 studies	35% ± 27%	Explore
lymph node	3 studies	32% ± 18%	Explore
brain	3 studies	20% ± 4%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
kidney	100%	1991.48	89 / 89	99%	33.93	896 / 901
prostate	100%	1704.48	245 / 245	99%	40.06	498 / 502
liver	99%	1724.60	224 / 226	100%	38.44	406 / 406
thymus	99%	1697.00	647 / 653	100%	40.85	605 / 605
intestine	99%	1449.39	961 / 966	99%	44.42	524 / 527
esophagus	99%	1703.06	1436 / 1445	99%	25.12	182 / 183
skin	99%	2413.04	1790 / 1809	100%	34.42	470 / 472
pancreas	99%	1464.78	325 / 328	99%	31.97	177 / 178
bladder	100%	1379.62	21 / 21	98%	33.12	496 / 504
brain	98%	1218.88	2599 / 2642	100%	25.97	705 / 705
stomach	99%	1557.82	355 / 359	99%	38.59	284 / 286
uterus	98%	1417.09	167 / 170	100%	38.97	458 / 459
breast	99%	1489.41	456 / 459	98%	28.38	1100 / 1118
adrenal gland	98%	2512.95	254 / 258	99%	33.07	228 / 230
ovary	98%	1843.41	176 / 180	100%	33.04	429 / 430
lung	99%	1528.17	570 / 578	99%	27.23	1140 / 1155
eye	0%	0	0 / 0	100%	77.13	80 / 80
lymph node	0%	0	0 / 0	100%	79.66	29 / 29
tonsil	0%	0	0 / 0	100%	40.51	45 / 45
ureter	0%	0	0 / 0	100%	44.95	1 / 1
spleen	100%	1747.04	240 / 241	0%	0	0 / 0
adipose	99%	1462.94	1196 / 1204	0%	0	0 / 0
muscle	99%	1942.80	794 / 803	0%	0	0 / 0
heart	99%	1890.75	850 / 861	0%	0	0 / 0
blood vessel	98%	1371.10	1311 / 1335	0%	0	0 / 0
peripheral blood	96%	1446.71	888 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006412	Biological process	translation
GO_0032543	Biological process	mitochondrial translation
GO_0005762	Cellular component	mitochondrial large ribosomal subunit
GO_0005739	Cellular component	mitochondrion
GO_0005743	Cellular component	mitochondrial inner membrane
GO_0001650	Cellular component	fibrillar center
GO_0003723	Molecular function	RNA binding
GO_0003735	Molecular function	structural constituent of ribosome
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	MRPL23
Protein name	Large ribosomal subunit protein uL23m (39S ribosomal protein L23, mitochondrial) (L23mt) (MRP-L23) (L23 mitochondrial-related protein) (Ribosomal protein L23-like) Large ribosomal subunit protein uL23m (39S ribosomal protein L23, mitochondrial)
Synonyms	RPL23L L23MRP
Description
Accessions	ENST00000397294.7 ENST00000672523.1 Q16540 A8MYK1 A6NJD9 ENST00000397298.8 ENST00000381519.5 ENST00000429295.1 ENST00000397297.7 A8MVT4 ENST00000672185.1 ENST00000381514.7 H7C2P7

MRPL23 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review